Ordering Recommendation

Screens for genetic susceptibility for venous thromboembolism (VTE) or myocardial infarction (MI) in individuals with a personal or family history of thrombotic events. Aids risk/benefit assessment for preventive or therapeutic interventions for VTE or MI.

New York DOH Approval Status

This test is New York state approved.

Specimen Required

Patient Preparation
Collect

Lavender (EDTA), pink (K2EDTA), or yellow (ACD solution A or B).

Specimen Preparation

Transport 3 mL whole blood. (Min: 1 mL)

Storage/Transport Temperature

Preferred transport temp: Refrigerated.

Unacceptable Conditions

Frozen specimens in glass collection tubes.

Remarks

Counseling and informed consent are recommended for genetic testing. Consent forms are linked above.
New York Clients: informed consent is required with submission.

Stability

Room temperature: 3 days; Refrigerated: 1 week; Frozen: 1 month

Methodology

Polymerase Chain Reaction (PCR) / Fluorescence Monitoring

Performed

Mon, Thu

Reported

7-10 days

Reference Interval

Refer to report

Interpretive Data

Refer to report

Compliance Category

Laboratory Developed Test (LDT)

Note

Hotline History

N/A

CPT Codes

81400

Components

Component Test Code* Component Chart Name LOINC
2004981 PAI-1 Specimen 31208-2
2004982 PAI-1 Interpretation 60577-4
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • FACV
  • PAI
  • PAI-1
  • Plasminogen Activator
  • PT PCR
  • SERPINE1
  • Thrombotic Risk Panel
Plasminogen Activator Inhibitor-1, PAI-1 (SERPINE1) Genotyping